Navigation Links
ABMS Selects Kevin B. Weiss, MD, MPH, as New President and CEO
Date:9/18/2007

EVANSTON, Ill., Sept. 18 /PRNewswire-USNewswire/ -- American Board of Medical Specialties (ABMS), the pre-eminent entity overseeing the certification of physician specialists in the United States, announced at its Interim Assembly Meeting today that its Board of Directors has appointed Kevin B. Weiss, MD, MPH, as the organization's new president and chief executive officer. Weiss will take up his new duties Dec. 17, 2007, and will join ABMS' Board of Directors. He succeeds retiring president and CEO Stephen H. Miller, MD, MPH.

Weiss has devoted more than 20 years of his medical career to quality and access issues in primary care, conducting epidemiological and health services research projects related to guideline implementation, chronic care management, outcomes measurement and quality improvement, with a specific emphasis on asthma. He served on Institute of Medicine (IOM) Committees that developed the reports "Crossing the Quality Chasm," and "Identifying Priority Areas for Quality Improvement." Recognizing the importance of patient safety and quality of care in his community, Weiss also helped found the Chicago Patient Safety Forum and served as its first chairperson.

"Joining ABMS at this time is a tremendous opportunity," Weiss said. "I think that ABMS is one of the strongest potential levers for change in the medical profession as we work to improve healthcare quality, improve efficiency, and address the rising costs of care."

Weiss described several goals for his new role at the helm of ABMS. "My immediate goals will be to work with all 24 ABMS Member Boards to complete implementation of Maintenance of Certification ahead of schedule, because it is a critically important process of continuous professional development. I also want to open up ABMS and its boards to more input from public members, and to establish a new evaluation program for physicians based on demonstrating high proficiency standards."

ABMS Board of Directors Ch
'/>"/>

SOURCE American Board of Medical Specialties
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. United States Department of Defense Selects Ichor Medical Systems to Develop Biodefense Vaccine
2. Clintons new problem - Is the outgoing American president suffering from skin cancer?
3. Past President Narayanans Condition Still Critical
4. President and Founder of National Obesity Forum Resigns
5. President Bush Urges Citizens to Invest In Health Savings Account (HSAs)
6. President Bush proposes HSAs scheme for the benefit of both the workers and the country
7. President’s verdict: no need to panic over bird fl
8. Delhi Hospitals On Standby For President Bush
9. Former IMO President Shows Interest In Winning General Election
10. Chicken Dishes Were Off The Menu At Pakistan Presidents House
11. Man Appeals to President to Save His Ailing Son
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2008)...ens Market to More Than 30 European Countries, HO.... announced today,that it has successfully complet...nd the Medical Device Directive (for most European...eted CE Mark -- or Conformite Europeene Mark,-- fo...xpands Hoana,s,patient safety reach to include mor...
(Date:8/29/2008)... Dr. Milton Owens and the Coastal Center for ...nia to provide protection for cash paying patients...nic community is benefiting. , ...r. Milton Owens and the Coastal Center for Obesity...provide protection for cash paying patients in the...
(Date:8/28/2008)... person with dementia led to daytime tiredness, sy...28 (HealthDay News) -- Older adults who live with ...ne with dementia have significantly worse sleep th... The study compared 31 caregivers and 102 noncareg...nutes less per night than non-caregivers and took ...
(Date:8/28/2008)...ad clinical efforts of the Maryland Medicaid contr...RO, a national medical,management firm, appointed ...al Director. Dr. Lawyer will oversee all clinical ...KePRO,s Hunt Valley, Maryland Harrisburg,office., ...er in Maryland," said,Alice Stollenwerk Petrulis, ...
Breaking Medicine News(10 mins):Health News:Hoana Medical Acquires CE Mark to Expand Patient Safety Technology to European Market 2Health News:Hoana Medical Acquires CE Mark to Expand Patient Safety Technology to European Market 3Health News:Hoana Medical Acquires CE Mark to Expand Patient Safety Technology to European Market 4Health News:Coastal Center for Obesity Offers Hispanics Weight Loss Surgery with a Warranty 2Health News:Older Caregivers Prone to Worse Sleep Patterns 2Health News:Lenaye Lawyer, MD, FACOG, Named KePRO Medical Director 2
...hat by adding more calcium to the diet may help re...er women.// In a study of more than 95,000 women w... 1,223 new kidney stones over the eight years of t...lcium had a 27-percent lower risk of developing ki...
...es occur each year in the United States. Investiga...n for // more than 50 years to see how various fac... stroke. In this sub-study, researchers compared t...istory of stroke.About 20 percent of the people wh...
...0 people in the United States suffer a stroke. Abo...es can // reduce the ability to perform daily func...g, bathing, walking and doing household chores. Re...hould be urged to exercise more at least 20 minute...
...ombination of a human papillomavirus ( HPV ) vacci...ical cancer risk // significantly. HPV causes near...dy it was found that , 65 percent of all cervical ...ceded by persistent infections with low-risk HPV. ...
Other Medicine News:
(Date:8/27/2008)...es Crucial Breakthrough in Battle to Prevent ...CAGO, Aug. 27 /- The British Midlands...ntists at The University of Nottingham,have made a...vent the onset,of a very common type of dementia a...etically produced the first ever mouse model,with ...
(Date:8/27/2008)... BLISS-52 trial, expected by mid-2009 - - Data fr...l 2009 -, ROCKVILLE, Md., Aug. 27 /PRNewswire-Fir...GSI ) today announced it has completed enrollment,...pivotal Phase 3,randomized clinical trials of Lymp...stemic lupus erythematosus (SLE). Belimumab is bei...
(Date:8/26/2008)...wswire/ -- Semafore Pharmaceuticals Inc.,announced...ess on Targeted,Therapies in Cancer in Washington,...of vascular-targeted PI3 kinase (PI3K) inhibitor S...PI3K is part of a very powerful pathway, the PI3/A...or role in cancer. Studies have shown that by,inhi...
(Date:8/26/2008).../- Healthpoint today announced,that i...ffectiveness of a,widely prescribed enzymatic debr...ing scars. The pilot study was prompted, in part, ...pertrophic scars and beneficial healing,properties...,2), "Given the findings from the peer-reviewed l...
Breaking Medicine Technology:The University of Nottingham in the British Midlands Announces Breakthrough in Parkinson's Disease Research 2Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 2Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 3Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 4Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 5Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 6SF1126, Semafore's PI3 Kinase Inhibitor, Found to Block Angiogenic Signaling From Both VEGF and Bv8 in Multiple Cell Lines 2SF1126, Semafore's PI3 Kinase Inhibitor, Found to Block Angiogenic Signaling From Both VEGF and Bv8 in Multiple Cell Lines 3Healthpoint Initiates Randomized, Double-Blind Study to Evaluate Effectiveness of Collagenase SANTYL(R) Ointment on Wound Healing 2Healthpoint Initiates Randomized, Double-Blind Study to Evaluate Effectiveness of Collagenase SANTYL(R) Ointment on Wound Healing 3Retina Group of New York To Present Seminar on Age Related Macular Degeneration 3B The Leading Cause of Visual Loss in Seniors 24388 1Retina Group of New York To Present Seminar on Age Related Macular Degeneration 3B The Leading Cause of Visual Loss in Seniors 24388 2Retina Group of New York To Present Seminar on Age Related Macular Degeneration 3B The Leading Cause of Visual Loss in Seniors 24388 3Mt Sinai 26apos 3Bs Children 26apos 3Bs Trauma Institute Treatment and Service Adaptation Center Receives Video Conferencing Donation From IVCi 24385 1Mt Sinai 26apos 3Bs Children 26apos 3Bs Trauma Institute Treatment and Service Adaptation Center Receives Video Conferencing Donation From IVCi 24385 2Rising energy food prices major threats to wetlands as farmers eye new areas for crops 4201 1Rising energy food prices major threats to wetlands as farmers eye new areas for crops 4201 2Rising energy food prices major threats to wetlands as farmers eye new areas for crops 4201 3Plant steroids offer new paradigm for how hormones work 4199 1Plant steroids offer new paradigm for how hormones work 4199 2Plant steroids offer new paradigm for how hormones work 4199 3
...(BUSINESS WIRE)--May 22, 2007 - Medtronic,(NYSE:MD...EAVOR,clinical trial program reinforcing the exist... drug-eluting coronary stent system.,Four-year res...trial and three-year results from the nearly 1,200...or is associated with sustained,safety, significan...
...ow Bifeprunox Maintained Stability,Significantly L...Lipid Profile Comparable with Placebo , MARIETTA, ...harmaceuticals, Inc., Wyeth Pharmaceuticals, a div...ted clinical study results on,bifeprunox, an inves...with schizophrenia, today at the 2007 annual meeti...
Other Medicine Technology:Medtronic Updates Long-Term ENDEAVOR I-II Clinical Data Showing,Sustained Safety and Significant Reductions in Repeat Procedures 2Medtronic Updates Long-Term ENDEAVOR I-II Clinical Data Showing,Sustained Safety and Significant Reductions in Repeat Procedures 3New Long-Term Data Analyses for Bifeprunox Show Favorable Effects,Versus Placebo in Stabilized Patients with Schizophrenia 2New Long-Term Data Analyses for Bifeprunox Show Favorable Effects,Versus Placebo in Stabilized Patients with Schizophrenia 3New Long-Term Data Analyses for Bifeprunox Show Favorable Effects,Versus Placebo in Stabilized Patients with Schizophrenia 4New Long-Term Data Analyses for Bifeprunox Show Favorable Effects,Versus Placebo in Stabilized Patients with Schizophrenia 5
...aboratory and a worldwide leader in innovative lab...xtensive test menu of highly complex and unique me...ned by the University of Utah, ARUP Laboratories' ...versity teaching hospitals and children's hospital...
...aboratory and a worldwide leader in innovative lab...xtensive test menu of highly complex and unique me...ned by the University of Utah, ARUP Laboratories' ...versity teaching hospitals and children's hospital...
...aboratory and a worldwide leader in innovative lab...xtensive test menu of highly complex and unique me...ned by the University of Utah, ARUP Laboratories' ...versity teaching hospitals and children's hospital...
...aboratory and a worldwide leader in innovative lab...xtensive test menu of highly complex and unique me...ned by the University of Utah, ARUP Laboratories' ...versity teaching hospitals and children's hospital...
Medicine Products: